Stemsation International, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a STSN research report →
Companywww.stemsation.global
StemSation International, Inc. develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body. It offers StemRCM, a dietary supplement that supports stem cells ability to repair, renew, and restore tissues and organ function through healthy stem cell release, circulation, and migration.
- CEO
- Ray C. Carter Jr.
- IPO
- 2008
- Employees
- 4
- HQ
- Boca Raton, FL, US
Price Chart
Valuation
- Market Cap
- $264.42K
- P/E
- -6.43
- P/S
- 0.00
- P/B
- 0.16
- EV/EBITDA
- -6.38
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -2.54%
- ROIC
- -1.79%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-464,305 · 48.22%
- EPS
- $0.00 · 122.58%
- Op Income
- $-391,120
- FCF YoY
- 20.96%
Performance & Tape
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.05
- Avg Volume
- 162.30K
Get TickerSpark's AI analysis on STSN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our STSN Coverage
We haven't published any research on STSN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate STSN Report →